MCRC for Rheumatic Diseases in African Americans

非裔美国人风湿病 MCRC

• 批准号: 8699679
• 负责人: Gary S Gilkeson
• 金额: $ 111.46万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-01 至 2017-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8699679
• 关键词: Address; Affect; African American; Autoimmune Process; Biological; Biometry; Clinical; Clinical Research; Collaborations; Communities; Connective Tissue Diseases; Consultations; Coupled; Development; Development Plans; Diagnosis; Disease; Disease Progression; Education; Epigenetic Process; Family; Fostering; Funding; Future; General Population; Genetic; Goals; Government Agencies; Health; Health Personnel; Health Professional; Home environment; Individual; Institution; Interdisciplinary Study; Island; Knowledge; Lead; Leadership; Life; Lung diseases; Lupus; Medical; Mentors; Methodology; Minority; Mission; Morbidity - disease rate; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Outcome; Outcomes Research; Pathogenesis; Patient Care; Patients; Pilot Projects; Population; Prevalence; Public Health; Pulmonary Fibrosis; Research; Research Infrastructure; Research Personnel; Resources; Rheumatism; Rheumatology; Risk; Sampling; Scleroderma; Sea; Severities; Sierra Leone; Solid; South Carolina; Staging; Strategic Planning; Systemic Lupus Erythematosus; Systemic Scleroderma; Translational Research; Trust; United States National Institutes of Health; Universities; Woman; Work; base; clinical care; design; dissemination research; genetic variant; health disparity; improved; innovation; interest; minority health; mortality; multidisciplinary; novel; outcome forecast; patient population; programs

The objective of this Multidisciplinary Clinical Research Center at the Medical University of South Carolina is the advancement of knowledge with respect to African Americans who have, or who are at risk of developing, systemic lupus erythematosus, systemic sclerosis, and other debilitating rheumatic diseases. The Center is built on a solid framework of strong leadership in Rheumatology, Biostatistics and Health Disparities Research coupled with trust and a proven track record of recruitment of African American patients for clinical research. Objectives of the Center are to: 1) conduct and foster translational clinical research leading to improved diagnosis, management and ultimately a reduction or elimination of health disparities with respect to debilitating rheumatic diseases in African Americans; 2) focus on identifying and understanding the underlying reasons for differences in risk profiles and disease progression for African Americans; 3) provide information and education to patients and families, healthcare providers, the general public, investigators and health professionals at other academic health centers and government agencies. We propose two innovative, high impact projects supported by three cores. Project 1 will investigate a genetic variant observed in African American SSc patients likely to be responsible for their higher severity of pulmonary fibrosis. This is highly significant given the morbidity and mortality rates, especially related to lung disease, in these patients. Project 2 addresses another significant health disparity, the increasing prevalence of lupus among African American women. The Sea Island Gullah people of South Carolina and individuals living in the Gullah ancestral home of Sierra Leone provide a novel opportunity to study genetic, environmental and epigenetic differences that might identify key factors associated with the development of SLE in African Americans. These two projects and future pilot projects will be served by three cores: (1) a Methodology Core will provide rigorous methodological and biostatistical support; (2) a Patient Resource Core will assure investigators access to patients and biological samples from SSc and SLE patients enriched with African Americans; (3) an Administrative Core will coordinate the work of the Center through planning, development, coordination and overall administration. With a sustained commitment of strong institutional support and through a robust pilot project program, this MCRC will attract and nurture young investigators with research interests in minority health and rheumatic diseases.

南卡罗来纳州医科大学的多学科临床研究中心的目标是提高对患有系统性红斑狼疮、系统性硬化症和其他使人衰弱的风湿性疾病的非洲裔美国人的认识。该中心建立在流变学，生物统计学和健康差异研究的强大领导力的坚实框架上，加上信任和招募非裔美国人患者进行临床研究的良好记录。该中心的目标是：1）进行和促进转化临床研究，从而改善诊断，管理，并最终减少或消除非裔美国人中衰弱性风湿性疾病的健康差异; 2）专注于识别和理解非裔美国人风险特征和疾病进展差异的根本原因; 3）向患者和家属、医疗保健提供者、公众、其他学术健康中心和政府机构的研究人员和健康专业人员提供信息和教育。 我们提出了两个创新的，高影响力的三个核心支持的项目。项目1将研究在非裔美国人SSc患者中观察到的一种遗传变异，这种变异可能是导致其肺纤维化严重程度较高的原因。考虑到这些患者的发病率和死亡率，特别是与肺部疾病相关的发病率和死亡率，这是非常重要的。项目2解决了另一个重大的健康差距，非裔美国妇女中狼疮的患病率日益增加。南卡罗来纳州的海岛Gullah人和居住在塞拉利昂Gullah祖居地的个人提供了一个新的机会来研究遗传、环境和表观遗传差异，这些差异可能会确定与非裔美国人SLE发展相关的关键因素。这两个项目和未来的试点项目将由三个核心提供服务：（1）方法学核心将提供严格的方法学和生物统计学支持;（2）患者资源核心将确保研究人员能够接触到富含非裔美国人的SSc和SLE患者的患者和生物样本;（3）行政核心将通过规划、发展、协调和全面管理来协调中心的工作。凭借强大的机构支持和强大的试点项目计划的持续承诺，该MCRC将吸引和培养对少数民族健康和风湿性疾病有研究兴趣的年轻研究人员。